Navigation Links
Low Blood Sodium Predicts Mortality in PAH Patients
Date:6/20/2008

Routine measurement could be a vital indicator for treating narrowing of lung arteries

FRIDAY, June 20 (HealthDay News) -- New research shows that people with chronically high blood pressure in the blood vessels of the lungs and low serum sodium levels have a very high mortality rate.

Low blood sodium -- called hyponatremia, or HN -- is a known indicator of advanced left heart failure, but the new study from the University of Pennsylvania researchers now connects it with right heart failure in patients with pulmonary arterial hypertension (PAH).

PAH, a syndrome marked by narrowing of the arteries in the lungs, causes the right ventricle of the heart to work harder to pump blood into the lungs for reoxygenation.

"This is the first study to show the powerful prognostic significance of low blood sodium in these patients," lead author Dr. Paul R. Forfia, a medical director of the Pulmonary Hypertension Program at the Hospital of the University of Pennsylvania, said in a prepared statement.

The findings, published in a June issue of American Journal of Respiratory and Critical Care Medicine, are important, because serum sodium is a routine lab measurement that could now be a vital indicator in PAH patients.

In a study of PAH patients, 85 percent in the group with HN died during a two-year follow-up period, compared with just 19 percent of the group without HN. The median survival time was less than nine months. All the patients with sodium concentration levels right around the low-end of the minimum recommended level died, while all those at least slightly above the minimum lived.

The two groups in the study were similar in age, sex, ethnicity and body mass index, but those with HN had significantly poorer kidney function and three times the likelihood of lower extremity edema along with echocardiogram indications of significantly worse right heart function. During two years of follow up, hospitalization for HN patients occurred twice as often, mostly for right heart failure.

"Thus, serum sodium has important implications regarding right heart dysfunction, clinical right heart failure, and patient outcome, and should not be overlooked in the clinical assessment of patients with PAH," Forfia said.

More information

The National Heart, Lung, and Blood Institute has more about pulmonary arterial hypertension.



-- Kevin McKeever



SOURCE: American Thoracic Society, news release, June 13, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Specific antagonism lowers blood pressure
2. Restricting Blood Flow May Help Heart Bypass Patients
3. FDA Updates Prescription Guidelines for Blood Thinner
4. Doctors Often Miss High Blood Pressure in Kids
5. Back to School Means Return of School Blood Drives
6. Blood-flow detector software show promise in preventing brain damage
7. FDA Approves New Roche West Nile Virus Blood Screening Test
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Laser blasts viruses in blood
10. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
11. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology: